#Ireland #Dublin #Healthcare Conference #Investor Relations #Jazz Pharmaceuticals

Jazz Pharmaceuticals Participates in 24th Annual Needham Healthcare Conference

On March 26, 2025, Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced its participation in the 24th Annual Needham Healthcare Conference. This event, which will take place virtually, provides a platform for the company to share insights into its innovative initiatives and current advancements in healthcare.

Scheduled for Wednesday, April 9, 2025, at 9:45 a.m. PT / 12:45 p.m. ET / 5:45 p.m. IST, Jazz's management will engage in a fireside chat. This interactive discussion is expected to highlight the company's ongoing efforts to transform the lives of patients through groundbreaking therapies and solutions.

In line with the event, an audio webcast of the fireside chat will be accessible via the Investor Relations section of Jazz Pharmaceuticals’ website. The recordings will also be available for 30 days after the live session, ensuring stakeholders and interested parties do not miss out on valuable insights and updates from the company.

About Jazz Pharmaceuticals

Jazz Pharmaceuticals plc is a global biopharmaceutical company dedicated to creating innovative medicines aimed at enhancing the quality of life for patients grappling with serious health conditions. With headquarters in Dublin, Ireland, the company prides itself on a diverse portfolio that includes leading therapies for sleep disorders, epilepsy, and a growing collection of oncology treatments.

The company’s philosophy revolves around a patient-centric approach, with a commitment to scientific excellence driving its research initiatives. Jazz Pharmaceuticals aims to address conditions often neglected by other therapeutic solutions, thus filling a critical gap in the treatment landscape. Their comprehensive pipeline includes medications that advance the care of patients suffering from debilitating diseases.

Jazz’s global team, comprising researchers, developers, and manufacturing personnel, collaborates across multiple countries to ensure that effective treatments reach patients worldwide. The company emphasizes not only the importance of their product offerings but also the collaborative efforts needed to navigate the complex challenges inherent in healthcare today.

As the healthcare sector continues to evolve, Jazz Pharmaceuticals remains at the forefront, adapting its strategies to align with the latest advancements in medicine and patient care. Participants in the Needham Healthcare Conference can expect detailed analyses of the company’s directions, including key research developments and future aspirations.

Due to the competitive nature of the biopharma industry, attending such conferences has become essential for companies like Jazz Pharmaceuticals, allowing them to engage with investors, healthcare professionals, and other stakeholders. These transparent discussions facilitate a better understanding of the market landscape and the intricacies involved in patient care solutions.

For more about Jazz Pharmaceuticals and its commitment to innovation and better healthcare, visit Jazz Pharmaceuticals' official website. As the conference approaches, all eyes will be on how Jazz Pharmaceuticals presents its future endeavors and reinforces its dedication to changing lives through medicine.